Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Ozempic, Wegovy could reverse severe liver disease, study suggests

by
May 6, 2025
in Health Care
0
Ozempic, Wegovy could reverse severe liver disease, study suggests

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study.

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known by brand names Ozempic and Wegovy, has the ability to counter metabolic dysfunction-associated steatohepatitis, or MASH, liver disease and some of its risk factors.

MASH is characterized by inflammation and scarring caused by fat buildup in the liver. It affects roughly 20 percent of adults in the U.S. and is closely associated with risk factors like Type 2 diabetes and high blood pressure, according to the Cleveland Clinic.

Researchers administered weekly injections — either a placebo or semaglutide — to 800 patients across 37 countries between 2021 and 2023.

More than half of participants had Type 2 diabetes, and 75 percent were obese.

After nearly 17 months of injections, 62.9 percent of semaglutide patients had less inflammation and fat accumulation in their livers; 34 percent of placebo patients saw the same results.

It also reduced liver scarring in 37 percent of patients, compared to the placebo’s 23 percent.

The study’s semaglutide subjects also saw 10.5 percent weight loss, as well as improvements in liver enzymes and liver fibrosis measurements.

Lead author Dr. Arun Sanyal said the study could offer a “promising new approach for millions of patients.”

“If approved, this could offer an additional therapeutic option for patients with MASH and fibrosis,” Sanyal said. “This is crucial, given the strong link between MASH and cardiovascular, metabolic, and renal conditions, where semaglutide has already shown established health benefits.”

Sanyal’s team plans to continue the research by studying 1,200 participants from 37 countries for up to five years to look into long-term liver issues.

Previous Post

Fewer than half of Americans trust FDA, CDC to do their job

Next Post

How halt in funding hurts efforts to ensure safety of patients in medical research

Next Post
How halt in funding hurts efforts to ensure safety of patients in medical research

How halt in funding hurts efforts to ensure safety of patients in medical research

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    Spanberger hits Earle-Sears over health care, education in new ad

    Spanberger hits Earle-Sears over health care, education in new ad

    September 22, 2025
    Trump administration halts government hunger report

    Trump administration halts government hunger report

    September 22, 2025
    Former acting CDC director says he ‘can’t look to’ center for trusted info 

    Former acting CDC director says he ‘can’t look to’ center for trusted info 

    September 21, 2025

    Trending

    Multistate Salmonella outbreak linked to pistachio cream: CDC

    Multistate Salmonella outbreak linked to pistachio cream: CDC

    June 16, 2025
    Anti-abortion group launches ad campaign in response to Georgia women’s deaths

    Anti-abortion group launches ad campaign in response to Georgia women’s deaths

    September 25, 2024
    Democrats investigating RFK Jr. bird flu response

    Democrats investigating RFK Jr. bird flu response

    April 2, 2025
    McDonald’s customer who spotted Luigi Mangione details encounter

    McDonald’s customer who spotted Luigi Mangione details encounter

    December 10, 2024

    Recent News

    Spanberger hits Earle-Sears over health care, education in new ad

    Spanberger hits Earle-Sears over health care, education in new ad

    September 22, 2025
    Trump administration halts government hunger report

    Trump administration halts government hunger report

    September 22, 2025

    Popular News

    • Spanberger hits Earle-Sears over health care, education in new ad
    • Trump administration halts government hunger report

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.